These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30904030)

  • 1. Comorbidity in multiple sclerosis: Past, present and future.
    Marrie RA
    Clin Invest Med; 2019 Mar; 42(1):E5-E12. PubMed ID: 30904030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course.
    Conway DS; Thompson NR; Cohen JA
    Mult Scler; 2017 Feb; 23(2):277-285. PubMed ID: 27230791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia.
    Marrie RA; Fisk JD; Stadnyk KJ; Tremlett H; Wolfson C; Warren S; Bhan V; Yu BN;
    Chronic Dis Inj Can; 2014 Jul; 34(2-3):145-53. PubMed ID: 24991777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity in multiple sclerosis: implications for patient care.
    Marrie RA
    Nat Rev Neurol; 2017 Jun; 13(6):375-382. PubMed ID: 28303911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.
    Salter A; Lancia S; Kowalec K; Fitzgerald KC; Marrie RA
    Neurology; 2024 Mar; 102(5):e209135. PubMed ID: 38350062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
    Kowalec K; McKay KA; Patten SB; Fisk JD; Evans C; Tremlett H; Marrie RA;
    Neurology; 2017 Dec; 89(24):2455-2461. PubMed ID: 29117961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review.
    Ewanchuk BW; Gharagozloo M; Peelen E; Pilutti LA
    Mult Scler Relat Disord; 2018 Nov; 26():19-32. PubMed ID: 30216755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for observational studies of comorbidity in multiple sclerosis.
    Marrie RA; Miller A; Sormani MP; Thompson A; Waubant E; Trojano M; O'Connor P; Fiest K; Reider N; Reingold S; Cohen JA;
    Neurology; 2016 Apr; 86(15):1446-1453. PubMed ID: 26865523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland.
    Kapica-Topczewska K; Tarasiuk J; Chorąży M; Czarnowska A; Brola W; Szczepański M; Kochanowicz J; Kułakowska A
    Mult Scler Relat Disord; 2020 Jun; 41():102051. PubMed ID: 32197130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.
    Hauer L; Perneczky J; Sellner J
    J Neurol; 2021 Nov; 268(11):4066-4077. PubMed ID: 32719975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression in multiple sclerosis: a review.
    Siegert RJ; Abernethy DA
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):469-75. PubMed ID: 15774430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSYCHIATRIC DISORDERS IN THE COURSE OF MULTIPLE SCLEROSIS.
    Główczyński P; Błachut M; Zając M; Badura Brzoza KA
    Wiad Lek; 2020; 73(8):1780-1784. PubMed ID: 33055351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia.
    Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
    Mult Scler; 2012 Sep; 18(9):1310-9. PubMed ID: 22328682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
    Marrie RA; Patten SB; Tremlett H; Wolfson C; Warren S; Svenson LW; Jette N; Fisk J;
    Neurology; 2016 Apr; 86(14):1279-1286. PubMed ID: 26962066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Barancik lecture: Comorbidity in multiple sclerosis-Looking backward, looking forward.
    Marrie RA
    Mult Scler; 2023 Aug; 29(9):1049-1056. PubMed ID: 37125430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of Multiple Sclerosis and Alzheimer's disease: A review.
    Luczynski P; Laule C; Hsiung GR; Moore GRW; Tremlett H
    Mult Scler Relat Disord; 2019 Jan; 27():232-238. PubMed ID: 30415025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability.
    Smith AE; Molton IR; Jensen MP
    Disabil Health J; 2016 Jul; 9(3):533-8. PubMed ID: 27009420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and anxiety adversely affect cognition in multiple sclerosis.
    Marrie RA; Patel R; Figley CR; Kornelsen J; Bolton JM; Graff L; Mazerolle EL; Marriott JJ; Bernstein CN; Fisk JD;
    Mult Scler Relat Disord; 2019 Jan; 27():164-170. PubMed ID: 30384203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
    Zhang T; Tremlett H; Leung S; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell TL; Stadnyk K; Yu BN; Marrie RA;
    Neurology; 2016 Apr; 86(14):1287-1295. PubMed ID: 26944268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of comorbidity in elderly patients with multiple sclerosis.
    Fleming ST; Blake RL
    J Clin Epidemiol; 1994 Oct; 47(10):1127-32. PubMed ID: 7722546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.